Aspergillus flavus scleritis: Successful treatment with voriconazole and caspofungin

Medical Mycology

Volumn 43, Issue 7, 2005, Pages 651-655

  Howell, Alan ^a   Midturi, John ^a   Sierra Hoffman, Miguel ^a   Carpenter, John ^a   Hurley, Douglas ^a   Winn, Richard ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Aspergillus scleritis; Caspofungin; Voriconazole

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; CREATININE; GLUCOCORTICOID; MOXIFLOXACIN; NONSTEROID ANTIINFLAMMATORY AGENT; VORICONAZOLE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ABSCESS; ABSCESS DRAINAGE; ADULT; ANAMNESIS; ARTICLE; ASPERGILLUS FLAVUS; CASE REPORT; CLINICAL FEATURE; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DRUG WITHDRAWAL; EYE BIOPSY; FEMALE; FUNGUS HYPHAE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PATIENT MONITORING; PHYSICAL EXAMINATION; SCLERITIS; TREATMENT OUTCOME;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FLAVUS; EYE INFECTIONS, FUNGAL; FEMALE; HUMANS; MIDDLE AGED; PEPTIDES, CYCLIC; PYRIMIDINES; SCLERITIS; TREATMENT OUTCOME; TRIAZOLES;

ASPERGILLUS; ASPERGILLUS FLAVUS; FUNGI;

EID: 30644460136     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780500271772     Document Type: Article

References (26)

1. PattersonTF. Aspergillus species. In: MandellGL, BennettJE, DolinR, eds. Principles and Practice of Infectious Diseases, 6th ed. Philadelphia: Churchill Livingstone2005; 2958-2973.
2. RichardsonMD, KokkiM. Aspergillus. In: AnaissieEJ, McGinnins DolinMR, PfallerMA, eds. Clinical Mycology, 1st ed. Philadelphia: Churchill Livingstone, 2003; 273-296.
3. Doft, BH and Clarkson, JG and Rebell, G and Forster, RK. (1980) Endogenous Aspergillus endophthalmitis in drug abusers Arch Ophthalmol, 98, pp. 859 - 862.
4. GoldsteinDA, TesslerHH. Episcleritis, scleritis, and other scleral disorders. In: YanoffM, DukerJS, eds. Ophthalmology, 2nd ed. St Louis: Mosby, 2004; 511-519.
5. Huang, FC and Huang, SP and Tseng, SH. (2000) Management of infectious scleritis after pterygium excision Cornea, 19, pp. 34 - 39.
6. Stenson, S and Brookner, A and Rosenthal, S. (1982) Bilateral endogenous necrotizing scleritis due to Aspergillus oryzae Ann Ophthalmol, 14, pp. 67 - 72.
7. Jager, MJ and Chodosh, J and Huang, AJW and Alfonso, EC and Culbertson, WW and Forster, RK. (1994) Aspergillus niger as an unusual cause of scleritis and endophthalmitis Br J Ophthalmol, 78, pp. 584 - 586.
8. Hemady, R and Sainz de la Maza, M and Raizman, MB and Foster, CS. (1992) Six cases of scleritis associated with systemic infection Am J Ophthalmol, 114, pp. 55 - 62.
9. Rodriguez-AresMT, De Rojas SilvaMV, PereiroM,. Aspergillus fumigatus scleritis, Acta Ophthalmol Scand 1995; 73: 467-469.
10. Carlson, AN and Foulks, GN and Perfect, JR and Kim, JH. (1992) Fungal scleritis after cataract surgery, successful outcome using itraconazole Cornea, 11, pp. 151 - 154.
11. Bernauer, W and Allan, BD and Dart, JK. (1998) Successful management of Aspergillus scleritis by medical and surgical treatment Eye, 12, pp. 311 - 316.
12. Hsiao, CH and Chen, JJ and Huang, SC and Ma, HK and Chen, PY and Tsai, RJ. (1998) Intrascleral dissemination of infectious scleritis following pterygium excision Br J Ophthalmol, 82, pp. 29 - 34.
13. Garg, P and Mahesh, S and Bansal, AK and Gopinathan, U and Rao, GN. (2003) Fungal infection of sutureless self-sealing incision for cataract surgery Ophthalmology, 110, pp. 2173 - 2177.
14. Kim, JE and Perkins, SL and Harris, GJ. (2003) Voriconazole treatment of fungal scleritis and epibulbar abscess resulting from scleral buckle infection Arch Ophthalmol, 121, pp. 735 - 737.
15. Reynolds, MG and Alfonso, E. (1991) Treatment of infectious scleritis and keratoscleritis Am J Ophthalmol, 112, pp. 543 - 547.
16. ChandlerJW. Textbook of Ophthalmology. St Louis: Mosby, 1994; 13.1-13.12.
17. Thomas, PA. (2003) Current perspectives on ophthalmic mycoses Clin Microbiol Rev, 16, pp. 730 - 797. 730-797
18. Groll, AH and Kolve, H. (2004) Antifungal agents: In vitro susceptibility testing, pharmacodynamics, and prospects for combination therapy Eur J Clin Microbiol Infect Dis, 23, pp. 256 - 270.
19. Denning, DW. (2003) Echinocandin antifungal drugs Lancet, 362, pp. 1142 - 1151.
20. Johnson, LB and Kauffman, CA. (2003) Voriconazole: A new triazole antifungal agent Clin Infect Dis, 36, pp. 630 - 637.
21. Sanati, H and Belanger, P and Fratti, R and Ghannoum, M. (1997) A new triazole, voriconazole (UK-109, 496), blocks sterol biosynthesis in Candida albicans and Candida krusei Antimicrob Agents Chemother, 41, pp. 2492 - 2496.
22. Diekema, DJ and Messer, SA and Hollis, RJ and Jones, RN and Pfaller, MA. (2003) Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi J Clin Microbiol, 41, pp. 3623 - 3626.
23. KakkaR, LeH, MontoyaJG. Clinical outcomes of combination therapy for invasive aspergillosis: Experience at one academic center [Abstract 81]. In: Advances Against Aspergillosis. San FranciscoCA, 2004.
24. ClemonsKV, EspirituM, ParmarR, StevensDA. Combination therapy studies using Ambisome, Amphotericin B deoxycholate, caspofungin, micafungin and voriconazole against CNS aspergillosis [Abstract M-1140]. In: 44th Intersci. Conf. Antimicrob. Agents Chemother, WashingtonDC, 2004.
25. MunozLS, RuthazerR, BoucherH, LoudonS, SkarfL, HadleyS. Combination antifungals for primary treatment of invasive aspergillosis: Do they work? [Abstract M-1024]. In: 44th Intersci. Conf. Antimicrob. Agents Chemother. WashingtonDC, 2004.
26. MeletiadisJ, PetraitisV, PetraitieneR,. Antagonistic interaction between liposomal amphotericin B and ravuconazole in experimental invasive pulmonary aspergillosis: Implications for combination therapy [Abstract M-238]. In: 44th Intersci. Conf. Antimicrob. Agents Chemother. WashingtonDC, 2004.